Cargando…
Melatonin attenuates doxorubicin‐induced cardiotoxicity through preservation of YAP expression
There are increasing concerns related to the cardiotoxicity of doxorubicin in the clinical setting. Recently, melatonin has been shown to exert a cardioprotective effect in various cardiovascular diseases, including cardiotoxic conditions. In this study, we examined the possible protective effects o...
Autores principales: | Li, Hai‐ru, Wang, Chao, Sun, Ping, Liu, Dan‐dan, Du, Guo‐qing, Tian, Jia‐wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131936/ https://www.ncbi.nlm.nih.gov/pubmed/32068341 http://dx.doi.org/10.1111/jcmm.15057 |
Ejemplares similares
-
Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression
por: Wang, Panxia, et al.
Publicado: (2021) -
Attenuation of doxorubicin-induced cardiotoxicity by esculetin through modulation of Bmi-1 expression
por: Xu, Fan, et al.
Publicado: (2017) -
Telomerase therapy attenuates cardiotoxic effects of doxorubicin
por: Chatterjee, Shambhabi, et al.
Publicado: (2021) -
Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
por: Xu, Haixia, et al.
Publicado: (2020) -
Synergistic cardioprotective effects of melatonin and deferoxamine through the improvement of ferritinophagy in doxorubicin-induced acute cardiotoxicity
por: Hanna, Mira, et al.
Publicado: (2022)